Medical Condition News RSS Feed - Medical Condition News

Hospitals that prevent cardiac arrests also have higher survival rates for cardiac arrest cases: Study

Hospitals with higher rates of survival among patients who experience in-hospital cardiac arrest also appear to have a lower incidence of in-hospital cardiac arrest, according to a study published Online First by JAMA Internal Medicine, a JAMA Network publication. [More]

Exercise-induced bronchoconstriction (EIB) guidelines: an interview with Dr Jonathan Parsons, The Ohio State University Asthma Center

Exercise-induced bronchospasm (EIB) is defined as acute, transient airway narrowing that occurs in association with exercise. Exercise-induced bronchospasm can occur during or, more frequently, after exercise. [More]

Roundup: Okla. governor pushes funding fix to cover 9,000 on Medicaid; Texas lawmakers OK new mental health funds

Gov. Mary Fallin proposed a last-minute legislative change Friday to the state's Insure Oklahoma program that would direct $50 million in state tobacco taxes to pay for more than 9,000 people who are expected to lose their health insurance under the program. [More]
Multiple studies examine ideal biomarkers for Huntington's disease

Multiple studies examine ideal biomarkers for Huntington's disease

While Huntington's disease (HD) is currently incurable, the HD research community anticipates that new disease-modifying therapies in development may slow or minimize disease progression. The success of HD research depends upon the identification of reliable and sensitive biomarkers to track disease and evaluate therapies, and these biomarkers may eventually be used as outcome measures in clinical trials. Biomarkers could be especially helpful to monitor changes during the time prior to diagnosis and appearance of overt symptomatology. [More]
The Biology of Cancer: New second edition now available

The Biology of Cancer: New second edition now available

Garland Science is proud to announce the publication of the much-anticipated Second Edition of The Biology of Cancer by Robert A. Weinberg. [More]
Pfizer halts Phase 3 open-label, two-arm study of lymphoma drug

Pfizer halts Phase 3 open-label, two-arm study of lymphoma drug

Pfizer Inc. announced today the discontinuation of a Phase 3 randomized, open-label, two-arm study (B1931008) evaluating the safety and efficacy of the investigational compound inotuzumab ozogamicin in patients with relapsed or refractory CD22+ aggressive non-Hodgkin lymphoma who are not candidates for intensive high-dose chemotherapy. [More]
Diachisis can occur during subacute phase of ischemic stroke, find USF researchers

Diachisis can occur during subacute phase of ischemic stroke, find USF researchers

While the effects of acute stroke have been widely studied, brain damage during the subacute phase of stroke has been a neglected area of research. Now, a new study by the University of South Florida reports that within a week of a stroke caused by a blood clot in one side of the brain, the opposite side of the brain shows signs of microvascular injury. [More]
Biogen Idec seeks FDA BLA approval for PLEGRIDY to treat multiple sclerosis

Biogen Idec seeks FDA BLA approval for PLEGRIDY to treat multiple sclerosis

Today Biogen Idec announced it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for approval of PLEGRIDY (peginterferon beta-1a), the company's pegylated subcutaneous injectable candidate for relapsing forms of multiple sclerosis (RMS). [More]
Choosing better sunscreen to protect family members

Choosing better sunscreen to protect family members

Like most over-the-counter products, not all sunscreens are created equal. Some sunscreens provide higher sun protection, while others contain ingredients that are better suited for children's skin. The key is choosing a sunscreen that will provide the best sun protection for all family members, and combining sunscreen use with other sun-smart behaviors. [More]

LBDA launches nationwide Lewy body dementia awareness movement

This year marks the tenth anniversary of the Lewy Body Dementia Association (LBDA), the only nonprofit organization in the United States dedicated to supporting LBD families through outreach, education and research. [More]

Blind people have potential to use echolocation to locate objects, new research shows

New research from the University of Southampton has shown that blind and visually impaired people have the potential to use echolocation, similar to that used by bats and dolphins, to determine the location of an object. [More]
UIC researchers to study gender differences in how the heart uses and stores fat

UIC researchers to study gender differences in how the heart uses and stores fat

Researchers at the University of Illinois at Chicago College of Medicine will study gender differences in how the heart uses and stores fat -- its main energy source -- and how changes in fat metabolism play a role in heart disease, under a new $2 million, 4-year grant from the National Heart, Lung and Blood Institute. [More]
Researchers say that receiving cancer radiation therapy late in the day may minimize hair loss

Researchers say that receiving cancer radiation therapy late in the day may minimize hair loss

Discovering that mouse hair has a circadian clock - a 24-hour cycle of growth followed by restorative repair - researchers suspect that hair loss in humans from toxic cancer radiotherapy and chemotherapy might be minimized if these treatments are given late in the day. [More]
Researchers develop new mouse model to discover gene pathways that drive MPNST

Researchers develop new mouse model to discover gene pathways that drive MPNST

University of Minnesota Medical School researchers from the Masonic Cancer Center, University of Minnesota, in partnership with the University's Brain Tumor Program, have developed a new mouse model of malignant peripheral nerve sheath tumors that allow them to discover new genes and gene pathways driving this type of cancer. [More]

Research explores pharmaceutical advances for IBS, hepatitis C

Research presented at Digestive Disease Week explores pharmaceutical advances for treating irritable bowel syndrome with diarrhea and hepatitis C. [More]
Researchers identify novel biomarkers for predicting mortality in ICU patients

Researchers identify novel biomarkers for predicting mortality in ICU patients

A metabolic profile of intensive care unit patients based on biomarkers of four metabolites can be used to accurately predict mortality, according to a new study. [More]
Men diagnosed with ADHD in childhood are at higher risk to suffer from obesity as adults: Study

Men diagnosed with ADHD in childhood are at higher risk to suffer from obesity as adults: Study

A new study conducted by researchers at the Child Study Center at NYU Langone Medical Center found men diagnosed as children with attention-deficit/hyperactivity disorder were twice as likely to be obese in a 33-year follow-up study compared to men who were not diagnosed with the condition. [More]

Lung Volume Reduction Coil may play key role in treatment of emphysema, study finds

A small, easily implantable device called the Lung Volume Reduction Coil may play a key role in the treatment of two types of emphysema, according to a study conducted in Europe. Results of the study indicate the beneficial effects of the device persist more than a year after initial treatment. [More]
WHO's Health Assembly opens 66th Session in Geneva

WHO's Health Assembly opens 66th Session in Geneva

WHO's Health Assembly, the world's largest health policy-making body, opened its 66th Session today in Geneva with around 3000 participants from around the world. [More]
AbbVie starts Phase 3 clinical study of atrasentan in patients with diabetic nephropathy

AbbVie starts Phase 3 clinical study of atrasentan in patients with diabetic nephropathy

AbbVie announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease and type 2 diabetes. [More]